Clinical trial

Phase II, Dose Finding Study of GTx-758

NCT01393119

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2011-08-01

PhasePHASE2

Study timeline

Study start (unknown)2011-08-01Date precision: month

Registry last updated2024-04-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

GTx-758DRUG

Sponsors & collaborators

GTxlead sponsor

Mapped research locations

CincinnatiOhio, United States1 ColumbusOhio, United States1 TampaFlorida, United States1 PhoenixArizona, United States1 AlbanyNew York, United States1 SyracuseNew York, United States1 St. PetersburgFlorida, United States1 ShreveportLouisiana, United States1 BradentonFlorida, United States1 AventuraFlorida, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01393119 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.